|16.60|| +0.19 / +1.16%|
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products. It specializes in the development, manufacture, and sale of biologic information from minute amounts of tissue. It offers nCounter Analysis System which directly profiles hundreds of molecules simultaneously using a novel barcoding technology to researchers in academic, government, and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of disease and to clinical laboratories and medical centers for diagnostic use. It also provides Prosigna Breast Cancer Assay which is a molecular diagnostic product that provides an assessment of a patient's risk of recurrence for breast cancer. The company was founded by Amber Ratcliffe, Krassen Dimitrov, and Dwayne Dunaway on June 20, 2003 and is headquartered in Seattle, WA.
|Robert Bradley Gray||President, Chief Executive Officer & Director|
|Mary Tedd Allen||Senior Vice President-Operations|
|James Algot Johnson||CFO & Principal Accounting Officer|
|Alessandra Cesano||Chief Medical Officer|
|Kathryn Surace-Smith||Secretary, Vice President & General Counsel|